tiprankstipranks
Trending News
More News >
Indivior PLC (INDV)
NASDAQ:INDV

Compare Indivior (INDV) vs. Competitors

Compare
196 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Indivior
$31.33
$3.66B
21.36
202.69%
3 Buy
0 Hold
0 Sell
Strong Buy
Neurocrine
$127.68
$12.81B
29.49
16.00%
21 Buy
2 Hold
0 Sell
Strong Buy
Supernus Pharmaceuticals
$47.76
$2.75B
-72.78
47.77%
5 Buy
1 Hold
0 Sell
Strong Buy
Teva Pharmaceutical
$28.73
$34.49B
25.43
76.91%
9 Buy
0 Hold
0 Sell
Strong Buy
Collegium Pharmaceutical
$35.44
$1.13B
21.64
18.41%
5 Buy
1 Hold
0 Sell
Strong Buy
Amneal Pharmaceuticals
$11.83
$3.72B
54.80
31.30%
4 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
INDV
Indivior
29.30
19.20
190.10%
NBIX
Neurocrine
127.68
12.08
10.45%
SUPN
Supernus Pharmaceuticals
47.76
15.06
46.06%
TEVA
Teva Pharmaceutical
28.73
12.55
77.56%
COLL
Collegium Pharmaceutical
35.44
4.88
15.97%
AMRX
Amneal Pharmaceuticals
11.83
2.94
33.07%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts